References
- Comenzo RL. How I treat amyloidosis. Blood 2009;114:3147–3157.
- Obici L, Perfetti V, Palladini G, Moratti R, Merlini G. Clinical aspects of systemic amyloid diseases. Biochim Biophys Acta 2005;1753:11–22.
- Browning MJ, Banks RA, Tribe CR, Hollingworth P, Kingswood C, Mackenzie JC, Bacon PA. Ten years' experience of an amyloid clinic – a clinicopathological survey. Q J Med 1985;54:213–227.
- Falk RH, Dubrey SW. Amyloid heart disease. Prog Cardiovasc Dis 2010;52:347–361.
- Pepys MB. Amyloidosis. Annu Rev Med 2006;57:223–241.
- Benson MD. The hereditary amyloidoses. Best Pract Res Clin Rheumatol 2003;17:909–927.
- Connors LH, Ericsson T, Skare J, Jones LA, Lewis WD, Skinner M. A simple screening test for variant transthyretins associated with familial transthyretin amyloidosis using isoelectric focusing. Biochim Biophys Acta 1998;1407:185–192.
- Comenzo RL, Zhou P, Fleisher M, Clark B, Teruya-Feldstein J. Seeking confidence in the diagnosis of systemic AL (Ig light-chain) amyloidosis: patients can have both monoclonal gammopathies and hereditary amyloid proteins. Blood 2006;107:3489–3491.
- Lachmann HJ, Booth DR, Booth SE, Bybee A, Gilbertson JA, Gillmore JD, Pepys MB, Hawkins PN. Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis. N Engl J Med 2002;346:1786–1791.
- JC Lee PH, TG Christensen PhD, L Connors PhD, and CJ O'Hara MD. The use of ultrastructural labeling (immunogold electron microscopy) in the classification of systemic amyloidosis. United States and Canadian Academy of Pathology Annual Meeting, Boston. Internet. 2009 March 7–13. Electronic Citation. http://www.abstracts2view.com/uscap09/view.php?nu=USCAP09L_1777. Last accessed 1 December 2010.
- Klein CJ, Vrana JA, Theis JD, Dyck PJ, Dyck PJ, Spinner RJ, Mauermann ML, Bergen HR III, Zeldenrust SR, Dogan A. Mass spectrometric-based proteomic analysis of amyloid neuropathy type in nerve tissue. Arch Neurol 2010:11. Available: http://archneur.ama-assn.org.ezproxy.bu.edu/cgi/content/full/archneurol.2010.261v1 via the Internet. Last accessed 1 December 2010.
- Lavatelli F, Perlman DH, Spencer B, Prokaeva T, McComb ME, Theberge R, Connors LH, Bellotti V, Seldin DC, Merlini G, et al. Amyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissue. Mol Cell Proteomics 2008;7:1570–1583.
- Vrana JA, Gamez JD, Madden BJ, Theis JD, Bergen HR III, Dogan A. Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens. Blood 2009;114:4957–4959.
- Dubrey SW, Cha K, Anderson J, Chamarthi B, Reisinger J, Skinner M, Falk RH. The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement. QJM 1998;91:141–157.
- Ebert EC, Nagar M. Gastrointestinal manifestations of amyloidosis. Am J Gastroenterol 2008;103:776–787.
- Falk RH, Comenzo RL, Skinner M. The systemic amyloidoses. N Engl J Med 1997;337:898–909.
- Picken MM, Herrera GA. The burden of “sticky” amyloid: typing challenges. Arch Pathol Lab Med 2007;131:850–851.
- Arbustini E, Verga L, Concardi M, Palladini G, Obici L, Merlini G. Electron and immuno-electron microscopy of abdominal fat identifies and characterizes amyloid fibrils in suspected cardiac amyloidosis. Amyloid 2002;9:108–114.
- Arbustini E, Morbini P, Verga L, Concardi M, Porcu E, Pilotto A, Zorzoli I, Garini P, Anesi E, Merlini G. Light and electron microscopy immunohistochemical characterization of amyloid deposits. Amyloid 1997;4:157–170.